1) Medical Countermeasures Initiative (MCMI)
Abstract
Medical Countermeasures Initiative (MCMI): Coordinate inter-related advanced development and flexible manufacturing capabilities, based on partnerships between the government and industry, providing a dedicated, cost-effective, reliable, and sustainable MCM process that meets the needs of the Warfighter and national security. Specifically, the MCMI provides a capability for the advanced development and flexible manufacturing of biological MCM (including TMT developed MCMs) to address CBRN threats, including novel and previously unrecognized, naturally-occurring emergent infectious diseases. MCMI efforts within S&T are concentrated in advancing two areas: 1) regulatory science and 2) flexible manufacturing technologies for MCMs.
Document Details
- Document Type
- Accomplishment
- Publication Date
- Oct 01, 2014
- Source ID
- 591132c0b6822c0065422ef3108e461d